Mell, Loren K <br/><br/>
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  03 2017 
 - 536-545 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2016.11.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnostic imaging<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow<br/>Brachytherapy--methods<br/>Carcinoma, Squamous Cell--diagnostic imaging<br/>Chemoradiotherapy--methods<br/>Cisplatin--therapeutic use<br/>Feasibility Studies<br/>Female<br/>Gastrointestinal Tract--radiation effects<br/>Humans<br/>Incidence<br/>Middle Aged<br/>Neutropenia--epidemiology<br/>Organ Sparing Treatments--methods<br/>Radiation-Sensitizing Agents--therapeutic use<br/>Radiotherapy Dosage<br/>Radiotherapy, Image-Guided--methods<br/>Radiotherapy, Intensity-Modulated--methods<br/>Uterine Cervical Neoplasms--diagnostic imaging